What is it used for?
CAMCEVI is indicated for the treatment of adult patients with advanced prostate cancer.CAMCEVI is indicated for the treatment of adult patients with advanced prostate cancer.
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- leuprolide mesylateleuprolide mesylate
- Form and strength
- INJECTION, EMULSION · 42 mg / 0.37 gINJECTION, EMULSION · 42 mg / 0.37 g
- Manufacturer / applicant
- ACCORD BIOPHARMA, INC.ACCORD BIOPHARMA, INC.
Injectable emulsion: 42 mg leuprolide (equivalent to approximately 48 mg leuprolide mesylate) as a sterile, off-white to pale yellow, viscous, and opalescent emulsion in a single-dose, pre-filled syringe for subcutaneous injection.Injectable emulsion: 42 mg leuprolide (equivalent to approximately 48 mg leuprolide mesylate) as a sterile, off-white to pale yellow, viscous, and opalescent emulsion in a single-dose, pre-filled syringe for subcutaneous injection.
Safety and clinical review
- Tumor FlareTumor Flare
- Hyperglycemia and DiabetesHyperglycemia and Diabetes
- Cardiovascular DiseasesCardiovascular Diseases
- QT/QTc ProlongationQT/QTc Prolongation
- ConvulsionsConvulsions
- Severe Cutaneous Adverse ReactionsSevere Cutaneous Adverse Reactions
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is CAMCEVI used for?
CAMCEVI is indicated for the treatment of adult patients with advanced prostate cancer.CAMCEVI is indicated for the treatment of adult patients with advanced prostate cancer.
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of CAMCEVI should I ask about?
INJECTION, EMULSION · 42 mg / 0.37 gINJECTION, EMULSION · 42 mg / 0.37 g
Read the primary sourceWhat determines the price of CAMCEVI?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using CAMCEVI?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.